SCHEMBL2654856

SCHEMBL2654856

Cc1cc(SCC(C)CCc2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCGR P47871 16/20 0.49
GIPR P48546 5/20 0.45
PPARD Q03181 3/20 0.44
GCG P01275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654473 0.92 GCGR (0.54) GCGRGIPRGCG
SCHEMBL2657436 0.89 GCGR (0.54) GCGRGIPRPPARD
SCHEMBL2654684 0.89 GCGR (0.47) GCGRGIPRPPARDGCG
SCHEMBL2655282 0.85 GCGR (0.51) GCGRGIPRPPARDGCG
SCHEMBL2656044 0.85 GCGR (0.42) GCGRGIPRPPARD
SCHEMBL2654697 0.84 GCGR (0.55) GCGRGIPRPPARDGCG
SCHEMBL2656116 0.84 GCGR (0.55) GCGRGIPRPPARDGCG
SCHEMBL2653257 0.84 GCG (0.42) GCGRGCG
SCHEMBL2655487 0.81 GCG (0.60) GCGRGCG
SCHEMBL2657426 0.80 GCGR (0.46) GCGRGIPRPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO claimed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed